Literature DB >> 34106340

Correction to: Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: infammatory response of SARS-CoV-2 patients.

Jean-Rémi Lavillegrand1,2, Marc Garnier2,3, Agathe Spaeth4, Nathalie Mario4, Geofroy Hariri1,2, Antoine Pilon4, Enora Berti2,5, Fabienne Fieux3, Sara Thietart1, Tomas Urbina1,2, Matthieu Turpin2,5, Lucie Darrivere3, Muriel Fartoukh2,5, Franck Verdonk3, Guillaume Dumas1, Alain Tedgui6, Bertrand Guidet1,2, Eric Maury1,2, Yannick Chantran7, Guillaume Voiriot2,5, Hafd Ait-Oufella8,9,10.   

Abstract

Entities:  

Year:  2021        PMID: 34106340      PMCID: PMC8188151          DOI: 10.1186/s13613-021-00879-5

Source DB:  PubMed          Journal:  Ann Intensive Care        ISSN: 2110-5820            Impact factor:   6.925


× No keyword cloud information.

Correction to: Ann Intensive Care 11:9 (2021) https://doi.org/10.1186/s13613-020-00798-x

After publication of the original article [1], an error was identified in Lucie Darrivere’s name. The incorrect name is: Lucie Darrivière. The correct name i: Lucie Darrivere. The original article has been corrected.
  1 in total

1.  Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: inflammatory response of SARS-CoV-2 patients.

Authors:  Jean-Rémi Lavillegrand; Marc Garnier; Agathe Spaeth; Nathalie Mario; Geoffroy Hariri; Antoine Pilon; Enora Berti; Fabienne Fieux; Sara Thietart; Tomas Urbina; Matthieu Turpin; Lucie Darrivere; Muriel Fartoukh; Franck Verdonk; Guillaume Dumas; Alain Tedgui; Bertrand Guidet; Eric Maury; Yannick Chantran; Guillaume Voiriot; Hafid Ait-Oufella
Journal:  Ann Intensive Care       Date:  2021-01-13       Impact factor: 6.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.